Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes

Audrey Pietrzyk-Nivau; Sonia Poirault-Chassac; Sophie Gandrille; Sidi-Mohammed Derkaoui; Alexandre Kauskot; Didier Letourneur; Catherine Le Visage; Dominique Baruch

doi:10.1371/journal.pone.0136652

Abstract

Hematopoietic stem cells (HSC) differentiate into megakaryocytes (MK), whose function is to release platelets. Attempts to improve in vitro platelet production have been hampered by the low amplification of MK. Providing HSC with an optimal three-dimensional (3D) architecture may favor MK differentiation by mimicking some crucial functions of the bone marrow structure. To this aim, porous hydrogel scaffolds were used to study MK differentiation from HSC as well as platelet production. Flow cytometry, qPCR and perfusion studies showed that 3D was suitable for longer kinetics of CD34⁺ cell proliferation and for delayed megakaryocytic differentiation far beyond the limited shelf-life observed in liquid culture but also increased production of functional platelets. We provide evidence that these 3D effects were related to 1) persistence of MK progenitors and precursors and 2) prolongation of expression of EKLF and c-myb transcription factors involved in early MK differentiation. In addition, presence of abundant mature MK with increased ploidy and impressive cytoskeleton elongations was in line with expression of NF-E2 transcription factor involved in late MK differentiation. Platelets produced in flow conditions were functional as shown by integrin αIIbβ3 activation following addition of exogenous agonists. This study demonstrates that spatial organization and biological cues synergize to improve MK differentiation and platelet production. Thus, 3D environment constitutes a powerful tool for unraveling the physiological mechanisms of megakaryopoiesis and thrombopoiesis in the bone marrow environment, potentially leading to an improved amplification of MK and platelet production.

Citation: Pietrzyk-Nivau A, Poirault-Chassac S, Gandrille S, Derkaoui S-M, Kauskot A, Letourneur D, et al. (2015) Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes. PLoS ONE 10(8): e0136652. https://doi.org/10.1371/journal.pone.0136652

Editor: Connie J. Eaves, B.C. Cancer Agency, CANADA

Received: October 30, 2014; Accepted: August 5, 2015; Published: August 27, 2015

Copyright: © 2015 Pietrzyk-Nivau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: These studies were made available through the funding from DIM Stem Pole, INSERM, Universities Paris Descartes, Paris Diderot, Paris Nord and grants from ANR (ANR-09-EBIO-001-01; ANR-09-EBIO-001-09; ANR-10-EMMA-009-01; ANR-11-BSV-010-01).

Competing interests: The authors have declared that no competing interests exist.

Introduction

Hematopoietic stem cells (HSC) isolated from hematopoietic tissues (bone marrow, peripheral blood and cord blood) are self-renewing, multipotent progenitors of hematopoietic lineages leading to all mature blood cells. Structural factors regulating HSC proliferation remain poorly investigated [1]. Inside a tissue structure, cells are organized within the complex molecular framework of the extracellular matrix (ECM). ECM molecules provide tissues with the appropriate three-dimensional (3D) architecture and influence cell migration, proliferation, and differentiation [2]. In order to improve in vitro HSC proliferation, 3D structures have been used as physical support to ECM proteins, increasing cell-cell and cell-substrate interactions [3,4].

In the megakaryocytic lineage, megakaryocyte (MK) progenitors proliferate and differentiate into MK precursors that become polyploid by endomitosis, i.e. DNA replication without cell division [5]. Platelets, which are essential for bleeding arrest, are formed from the enlarged cytoplasm of mature MK [5]. MK differentiation occurs in vitro in the presence of thrombopoietin (TPO), an essential cytokine for HSC proliferation and differentiation, acting as a MK proliferation, maturation and differentiation agonist [6].

In the bone marrow, interactions between bone cells, hematopoietic cells and vascular cells regulate hematopoiesis. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis, the final step of MK differentiation [7]. This process consists of proplatelet formation and platelet release into the circulation from MK fragments entering sinusoid vessels. Platelet release is not synchronized in liquid culture, resulting in a low platelet yield. Platelet production in vitro remains a challenging task, requiring synergy between biochemical and biophysical factors to reach high platelet yields. Thus, in the aim to improve in vitro platelet production, several novel approaches are currently developed. Hemodynamic shear forces contribute to proplatelet and platelet formation from mature MK in vivo [8] and in vitro [9]. We reported that platelet production in vitro is accelerated and concentrated in flow conditions [10], a process that has been recently reproduced by two others groups [9,11]. A synergy between environment factors has been shown to be involved in i) MK differentiation within the osteoblastic niche of the bone marrow [12], ii) MK migration to the vascular niche [13], and iii) platelet production from fully mature MK [10]. Indeed, most key events occurring during MK maturation appear to be reproduced ex vivo in liquid culture, except for the regulatory activities normally provided by the structural bone marrow microenvironment [14]. Even if MK differentiation studies in 3D environment are available [9,11–13,15,16], information is still lacking on the influence of 3D organization not only on thrombopoiesis but also on megakaryopoiesis. 3D biomaterials formed by assembling polymers or biomolecules such as proteins or natural polysaccharides are extensively used in regenerative medicine. Hydrogels have proved valuable for expanding endothelial progenitor cells and for differentiating embryonic stem cells [17,18]. So far, high yields of platelets have been achieved ex vivo from HSC using 3D scaffolds of nonwoven polyester fabric and inverted colloidal crystals/polyacrylamide porous hydrogels, but these platelets seemed activated [16]. Nevertheless, MK differentiation leading to this increased platelet production was not investigated in any of these 3D structures.

In this study, we examined how a porous 3D structure affects HSC proliferation, MK differentiation and platelet production. The results clearly demonstrate the effect of 3D environment not only on CD34⁺ cell proliferation but also on MK differentiation. We found that on one hand, 3D environment delayed MK progenitors (CD34⁺/CD41^-) differentiation into MK precursors (CD34^-/CD41⁺) leading to mature MK (CD41⁺/CD42b⁺). On the other hand, 3D environment improved enlargement of these mature MK allowing increased platelet production in flow conditions.

Materials and Methods

Three-dimensional hydrogels

3D scaffolds were prepared from polysaccharide-based hydrogels as previously described [19,20]. Hydrogels were composed of a 75:25 ratio of pullulan (MW 200 000; Hayashibara Inc, Okayama, Japan) and dextran (MW 500 000; Pharmacia, Uppsala, Sweden) at a concentration of 30% in water (w/v). The resulting hydrogels were porous and were obtained as dry disks of 5 mm in diameter and 1 mm thickness. They were used as a tool to reproduce the 3D environment required for CD34⁺ cell culture in comparison to liquid cell culture.

To study MK differentiation and platelet production in 3D hydrogels, enzymatic lysis of polysaccharides was used to recover the cell suspensions (3D cells). Pullulanase (from Bacillus acidopullulyticus, 44.4 U/mL; Sigma-Aldrich, Saint-Quentin Fallavier, France) and dextranase (from Chaetomium erraticum, 5.3 U/mL; Sigma-Aldrich) were added to 3D hydrogels for 30 minutes at 37°C, unless otherwise stated. Following scaffold degradation, cells were recovered by centrifugation for 10 minutes at 290g and compared to cells cultured in liquid conditions (liquid-culture cells). Controls consisted of liquid-culture cells that were added to empty 3D hydrogels immediately before enzymatic treatment. In some experiments, enzymatic treatment of 3D hydrogels was followed by a bovine serum albumin (BSA; PAA Laboratories, Vélizy Villacoublay, France) density gradient centrifugation to separate matrix debris from viable cells (S1 Fig) [21].

CD34⁺ cell culture and differentiation

CD34⁺ cells were isolated from human umbilical cord blood (UCB), peripheral blood or bone marrow by using an immunomagnetic technique (Miltenyi Biotec, Paris, France) [22]. This study was approved by the ethics committee/institutional review board “Assistance Publique-Hôpitaux de Paris, Cord Blood Bank, Saint-Louis Hospital, Paris, France” with women’s written informed consent. In order to control for inter-individual variations, CD34⁺ cell samples were separated in two aliquots of 300 000 cells, one for liquid culture and one for 3D hydrogel culture. For liquid culture, 150 000 cells/cm² (Greiner Bio-One, Les Ulis, France) were added and for 3D hydrogel culture, 3 dry disks were seeded with 100 000 cells each (0.2 cm²/disk thus 500 000 cells/cm²; S1 Fig). The disks were placed in 1-cm² wells, as their volume increased during gradual incorporation of CD34⁺ cells and rehydration by stepwise addition of medium. In both conditions, CD34⁺ cells were cultured at 37°C with 5% CO₂ in complete medium: Iscove modified Dulbecco’s medium (IMDM; Gibco-Invitrogen, Saint-Aubin, France) supplemented with 15% BIT 9500 serum substitute (Stem Cells Technologies, Grenoble, France), α-monothioglycerol (Sigma-Aldrich) and liposomes (phosphatidyl-choline, cholesterol and oleic acid; Sigma-Aldrich) [22]. Human recombinant stem cell factor (SCF, 20 ng/mL; Miltenyi Biotec) and the thrombopoietin peptide agonist AF13948 named TPO (50 nM) [10] were added once on day 0 to the culture medium, followed by 20 nM TPO alone without any addition of SCF thereafter. In liquid culture, cells were centrifuged and fresh medium with 20 nM TPO was added on days 7, 9 and 12. In 3D hydrogel culture, the disks were transferred to new wells when fresh medium with 20 nM TPO was added, on days 7, 9, 12, 16, 23 and 30 (S1 Fig). When the pores were fully occupied, some cells accumulated at the bottom of the wells. These cells were discarded when the hydrogels were transferred to new wells for medium renewal (S1 Fig). In this way, 3D cells were clearly distinguished from liquid-culture cells.

Online supplemental data available on the PLOS One website described in detail the materials and methods listed below:

-. Flow cytometry used for study of differentiation markers and ploidy
-. Confocal immunofluorescence microscopy
-. Clonogenic assay
-. RNA extraction and real-time qPCR
-. Platelet production in flow assay
-. Platelet activation and spreading
-. Statistical data analysis

Results

Kinetics of cell growth in 3D environment

The 3D environment was designed for optimal CD34⁺ cell proliferation and differentiation. Rehydrated transparent 3D hydrogels were organized into a complex network of large (200 μm) pores (Fig 1A). UCB-derived CD34⁺ cells loaded on top of 3D entered pores within one hour after seeding (not shown). Pore occupancy by proliferating cells was dependent on the initial number of cells, and a condition of 100 000 cells/disk was selected for further experiments (Fig 1A). Cells maintained in 3D survived for at least 36 days (Fig 1B), whereas cells in liquid culture survived for no more than 16 days (Fig 1C). This was confirmed by TUNEL assay performed on day 16 of cells in liquid culture showing many apoptotic cells (data not shown). 3D hydrogel transparency allowed visualizing and studying cell behavior inside pores: cell clusters started to be visible on the second day. Cells proliferated and differentiated, as shown on 9 different microphotographs taken at 3–4 day intervals between the 2^nd and 36^th day of 3D culture (Fig 1B). In order to estimate kinetics of total cell proliferation, cells grown in 3D and liquid culture were counted by means of image analysis (Fig 2A). Between day 6 and day 23, in 3D, total cell number increased (4.09 x 10⁶ ± 2.29 x 10⁶ on day 6 and 1.89 x 10⁷ ± 1.36 x 10⁷ on day 23; p<0.05) whereas in liquid culture, total cell number increased to reach a peak value of 2.6 x 10⁷ ± 2.75 x 10⁷ on day 9, then decreased until day 16 where total cell number did not differ between the two conditions (1.5 x 10⁷ ± 1.2 x 10⁷ in 3D vs 1.8 x 10⁷ ± 1.6 x 10⁷ in liquid culture; NS). After day 16, whereas no cell survived in liquid culture, cells were maintained in 3D up to day 36. Thus, 36 days after initial seeding, large numbers of cells were still present in 3D (Fig 2A). Therefore, an apparent delay in HSC proliferation was observed in 3D that lasted 20 days after the end of cell survival in liquid culture.

Download:

Fig 1. Cell morphology in 3D and in liquid culture.

(A) Cell proliferation 12 days after cell seeding, relative to the initial cell number/scaffold. (B) Cell proliferation and differentiation in 3D between day 2 and day 36. (C) Cell proliferation and differentiation in liquid culture on days 2, 12 and 16. All images were acquired using the Axiovert 135 transmission optical microscope with 20X Plasdic magnification. Scale bar = 20 μm.

https://doi.org/10.1371/journal.pone.0136652.g001

Download:

Fig 2. Comparison of total cell number and total CD41⁺ cell number in 3D environment and in liquid culture.

(A) Histogram representation of total cell number at different days of culture in 3D (black bars) and liquid culture (white bars). Proliferation was determined by cell imaging (Histolab), rather than by colorimetric assay, as polysaccharides produced a high background in the pNPP and MTT assays. Data are means ± SEM of 3 independent experiments. In 3D, late time points (D23 and D36) were compared to day 6. *p<0.05. Some cells exit from hydrogel pores, accumulated at the bottom of the wells (see Fig 1A) and therefore dismissed from the counts. Thus, only cells visible inside the pores of the 3D hydrogel were analyzed. (B) Histogram representation of total CD41⁺ cell number in 3D (black bars) and liquid culture (white bars) at different days of culture. Total CD41⁺ cell number was determined by multiplying the total cell number by the frequency of CD41⁺ cells. Data are means ± SEM of 3 independent experiments. In 3D, late time points (D23 and D36) were compared to day 6. Abbreviation: TCN, total cell number.

https://doi.org/10.1371/journal.pone.0136652.g002

To determine whether this delayed cell proliferation resulted in MK differentiation in liquid culture preceding that of cells in 3D, we estimated total CD41⁺ cell (MK precursors) number in both conditions. Results showed a peak of total CD41⁺ cell number on day 12 in liquid culture (2.07 x 10⁷ ± 1.2 x 10⁷) compared with a peak on day 16 in 3D (1.39 x 10⁷ ± 1.2 x 10⁷) followed by MK precursor presence until day 36 (Fig 2B). Taken together, these results indicated that 3D environment was suitable for longer kinetics of CD34⁺ cell proliferation and for delayed megakaryocytic differentiation.

MK differentiation in 3D environment

To investigate if 3D structure may provide specific information for efficient in vitro megakaryopoiesis, UCB-derived CD34⁺ cell differentiation was analyzed by studying the kinetics of CD34, CD41 and CD42b expression (Fig 3). From day 6 to day 15, CD41 and CD42b expression was similar in 3D and liquid culture (Fig 3A–3F), with decreasing percentage of non-megakaryocytic cells (CD41^-/CD42b^-; Fig 3A) and increasing percentages of MK precursors (CD41⁺/CD42b^-; Fig 3C) and of mature MK (CD41⁺/CD42b⁺; Fig 3E). This was also found when total number of non-megakaryocytic cells (Fig 3B), MK precursors (Fig 3D) and mature MK (Fig 3F) were taken into account. A significant population of CD34^+high cells with a MFI > 10³ was present on day 9 in 3D (11.3%) but absent in liquid culture. Moreover, CD34⁺ cells remained in 3D (31.5% ± 9.7% on day 9 and 6.4% ± 4.9% on day 16) while they disappeared in liquid culture (27.9% ± 12.4%; NS on day 9 and 2.6% ± 2.8%; p<0.05 on day 16) (Fig 3G). Interestingly in 3D from day 16 to day 23, a CD34⁺ cell population persisted (Fig 3G), while CD41 and CD42b were expressed by mature MK (Fig 3E). After day 16, no cells survived in liquid culture as visualized with 7AAD marker (data not shown). These results confirmed the delayed of MK differentiation in 3D environment. Thus, 3D environment provided a suitable environment for maintenance of hematopoietic progenitor CD34⁺ cells.

Download:

Fig 3. Characterization of MK differentiation as a function of time.

(A, C, E) Frequency of non-megakaryocytic cells (CD41^-/CD42b^-), MK precursors (CD41⁺/CD42b^-) and mature MK (CD41⁺/CD42b⁺) in 3D (closed circles, dotted lines) and liquid culture (open squares, full lines) between day 6 and day 36. Data are means ± SEM of 3 independent experiments.*p<0.05. In 3D, late time points (D23 and D36) were compared to day 6. (B) Histogram representation of total CD41^-/CD42b^- cell number in 3D (black bars) and liquid culture (white bars) at different days of culture. (D) Histogram representation of total CD41⁺/CD42b^- cell number in 3D (black bars) and liquid culture (white bars) at different days of culture. (F) Histogram representation of total CD41⁺/CD42b⁺ cell number in 3D (black bars) and liquid culture (white bars) at different days of culture. Total cell number of each MK population was determined by multiplying the total cell number by the frequency of each MK population. Data are means ± SEM of 3 independent experiments. In 3D, late time points (D23 and D36) were compared to day 7. *p<0.05. (G) CD41/CD34 dot plots of one representative experiment of 3 independent experiments in 3D and liquid culture on days 9, 16 and 23. Abbreviation: TCN, total cell number.

https://doi.org/10.1371/journal.pone.0136652.g003

To confirm more precisely the influence of 3D on non-megakaryocytic cell differentiation, we studied other hematopoietic lineages (S2 Fig). In particular, we identified the presence of myelomonocytic cells (CD11b⁺ and CD11b⁺/CD14⁺ cells) and macrophages (CD14⁺ cells) on days 23 and 36 (Panel A in S2 Fig). In addition, cells expressing the glycophorin A (GpA) erythropoietic marker in 3D persisted during the differentiation between day 6 and day 36 (Panel B in S2 Fig).

In addition, in 3D, bipotent progenitors characterized by CD41⁺/GpA⁺ cells [23] persisted at late time points (19.8% ± 4.8% on day 23 and 15.4% ± 8.8% on day 36; Fig 4A). These bipotent progenitors were also identified by studying megakaryocyte-erythroid progenitors (MEP) characterized as CD34⁺/CD41^-/CD45RA^-/CD123^- cells, 7 and 23 days after seeding. On day 7, the MEP percentage did not differ between the two conditions (23.4% ± 3.8% in 3D and 20.2% ± 4.6% in liquid culture; Fig 4B). On day 23, although decreased compared to day 7, MEP percentage persisted in 3D (0.4% ± 0.1%; p<0.05).

Download:

Fig 4. Characterization of CFU-MK and MEP.

(A) Frequency of CD41⁺/GpA⁺ cells in 3D (closed circles, dotted lines) and liquid culture (open squares, full lines) between day 7 and day 36. Data are means ± SEM of 4 independent experiments. In 3D, late time points (D23 and D36) were compared to day 7. (B) Frequency of MEP in 3D (black bars) and liquid culture (white bars) on days 7 and 23. Data are means ± SEM of 4 independent experiments. *p<0.05 between day 7 and day 23 in 3D. (C) Total number of CFU-MK produced from the expansion of 25 000 CD34⁺ cells in 3D (black bars) and liquid culture (white bars) on days 16 and 23. Data are means ± SEM of 4 independent experiments.*p<0.05. In 3D, day 23 was compared to day 16. (D) Histogram representation of CFU-MK areas on small and medium colonies, in 3D (black bars) and liquid culture (white bars) on day 16. Small and medium colonies were previous classified according to standard classification: small colonies; 3–21 cells/colony and medium colonies; 21–50 cells/colony. Data are means ± SEM of 90 independent colonies. **p<0.01. (E) Representative images of CFU-MK areas in 3D and liquid culture on day 16. Images were acquired using the Leica DM40000 B transmission optical microscope with 63X objective. Bar = 10 μm. Abbreviations: CFU-MK, colony forming unit-megakaryocyte; MEP, megakaryocyte-erythroid progenitors.

https://doi.org/10.1371/journal.pone.0136652.g004

CFU-MK potential was assessed in clonogenic assays performed with 3D cells recovered on days 16 and 23 and with liquid-culture cells recovered on day 16 (Fig 4C and 4D). The number of CFU-MK on day 16 was significantly higher in 3D (556 ± 101) than in liquid culture (224 ± 88; p<0.05) (Fig 4C). On day 23, CFU-MK colonies were still observed in 3D, in numbers similar to those seen in liquid culture on day 16 (Fig 4C). Based on standard classification, no significant difference was observed in the number of small (3–21 cells/colony) and medium (21–50 cells/colony) colonies between both conditions (data not shown). This indicated that cell proliferation was similar in 3D and liquid culture. As shown in Fig 4D and 4E, CFU-MK colonies produced by cells recovered on day 16 were larger in 3D (2497 ± 239 μm² in small colonies and 8645 ± 1522 μm² in medium colonies) than in liquid culture (1765 ± 120 μm²; p<0.01 in small colonies and 7446 ± 934 μm²; NS in medium colonies). Thus, MK progenitors were able to differentiate into more mature larger MK.

To support our previous results, we analyzed several transcription factors involved in megakaryopoiesis [24–26]. Therefore, we measured by RT-qPCR [27] different gene expression products at day 9 in both conditions and at days 16 and 23 in 3D (Fig 5). On day 9, the expression of EKLF was increased in 3D in comparison to liquid culture. In contrast, the expression of other genes was not different in both conditions (Fig 5A). In 3D, the expression of EKLF involved in early MK differentiation [24,25] decreased between day 9 and day 23 whereas the expression of RUNX-1 and NF-E2 involved in late MK differentiation [24–26] significantly increased (RUNX-1: 17.7% ± 8% on day 9 and 84.9% ± 8.5% on day 23, p<0.05; NF-E2: 31.7% ± 16.2% on day 9 and 87% ± 6.1% on day 23, p<0.05; Fig 5B). c-myb, gene involved in early MK differentiation, also significantly increased between day 9 and day 23 (71.4% ± 9% on day 9 and 97.6% ± 9.4% on day 23; p<0.05). In addition, the expression of GATA-1 and FLI-1 genes, involved in MK progenitor and precursor differentiation [24,25], increased between day 9 and day 16 and then decreased until day 23. The persistence of genes involved in early MK differentiation such as EKLF and c-myb, at late time point (day 23) was in line with the results of flow cytometry (MEP) and clonogenic assay (CFU-MK). Altogether, the persistence of MK progenitors, MK precursors and mature MK associated with late mRNA expression of several transcription factors provided strong evidence that 3D environment support on MK differentiation.

Download:

Fig 5. Transcriptional analysis of different genes involved in MK differentiation.

(A) Histogram representation of the expression levels of various genes determined by RT-qPCR in 3D (black bars) and liquid-culture (white bars) cells at day 9. (B) Histogram representation of time-dependent expression levels of various genes determined by RT-qPCR in 3D cells at days 9 (white bars), 16 (gray bars) and 23 (white bars). mRNA percentage of each gene was normalized to that of HPRT mRNA percentage and calibrated via the ΔΔCt method [27]. Data are means ± SEM of 3 independent experiments.*p<0.05. In 3D, days 16 and 23 were compared to day 9. Commercial references of the primer mixes used for qPCR are detailed in S1 Table.

https://doi.org/10.1371/journal.pone.0136652.g005

Cell ploidy in 3D environment.

To better characterize the mechanism of MK differentiation in 3D, UCB CD34⁺ cells were stained within the hydrogels. As shown in Fig 6, 12 days after seeding, MK precursors (CD41⁺/CD42b^- cells) and mature MK (CD41⁺/CD42b⁺ cells) were both present in 3D (Fig 6A-I), as in liquid culture (Fig 6A-II). In addition, nuclear staining indicated the presence of tetraploid cells within 3D (Fig 6A-III), contrary to liquid culture where diploid cells were mostly seen (Fig 6A-IV).

Download:

Fig 6. In situ characterization of differentiation markers and ploidy of mature MK.

(A) Immunofluorescence staining of CD41 (green) and CD42b (red) cells growing inside pores of 3D (I) and in liquid culture (II). Nuclear staining of cell grown in 3D (III) and liquid culture (IV) with YOYO-1 marker (white). All images were acquired 12 days after seeding using the Leica 510 confocal microscope with 40X Plan-NeoFluar objective lens. Scale bar = 10 μm. (B) Representative flow cytometry ploidy analysis of CD41⁺/CD42b⁺ UCB cells from 3D and liquid culture, 11 days after seeding. (C) Ploidy analysis of CD41⁺/CD42b⁺ UCB cells in 3D (black bars) compared to liquid culture (white bars), 11 days after seeding. Data are means ± SEM of 3 independent experiments. *p<0.05. Abbreviation: UCB, umbilical cord blood.

https://doi.org/10.1371/journal.pone.0136652.g006

Ploidy of UCB mature MK was further investigated 11 days after seeding by flow cytometry assessment of nuclear markers. Cells were recovered from hydrogels by enzymatic degradation of the pullulan-dextran structure in conditions providing the highest recovery while maintaining cell integrity, as determined by microscopy and analysis of surface markers (data not shown). Ploidy levels determined after selection of mature MK (CD41⁺/CD42b⁺ cells selected in singlet cells in division phases) showed a higher ploidy in 3D than in liquid culture (Fig 6B). Cumulative data of three independent experiments showed significantly higher percentages of 4N ploidy classes in 3D mature MK than in liquid-culture mature MK (30.5% ± 2.34% vs 19.1% ± 3.45%; p<0.05), whereas 2N ploidy was significantly increased in liquid culture than in 3D (78.1% ± 4.04% vs 64.2% ± 2.98%; p<0.05; Fig 6C). The percentage of >8N ploidy classes was not significantly different between both conditions (4.4% ± 0.59% in 3D vs 2.3% ± 0.96% in liquid culture; Fig 6C). Moreover, within in each ploidy class, CD41⁺/CD42b⁺ cells were larger when obtained from 3D than from liquid cultures (data not shown). These results showed that the 3D environment enhanced megakaryocytic maturation by favoring endomitosis.

MK differentiation from adult cells

Culture of adult bone marrow and peripheral blood CD34⁺ cells in 3D environment (S3 Fig) yielded results similar to those obtained with cord blood cells (Panel A in S3 Fig). Twelve days after seeding, the percentages of CD34⁺/CD41^- cells (non-megakaryocytic cells and cell progenitors) derived from bone marrow cells (Panel B in S3 Fig, middle) were higher in 3D (25.9%) than in liquid culture (16.9%), as observed with cord blood cells (Panel B in S3 Fig, left). Likewise, using peripheral blood cells, these percentages were also higher in 3D than in liquid culture (32.4% ± vs 22.8%; Panel B in S3 Fig, right). Overall, these results showed that 3D environment represents a way to increase the yield of platelet-forming MK derived from both neonatal and adult CD34⁺ cells.

Mature MK cultured in 3D produce more platelets in flow conditions than liquid-culture MK

In order to demonstrate that culture in 3D yielded platelets, platelet production was studied in flow conditions after recovery of mature and viable MK from 3D on day 16. When exposed to a high shear rate in a microfluidic platform (S1 Fig), mature MK were able to elongate and to be fragmented into proplatelets and platelets (Fig 7A and S1 Video). As previously shown for platelets derived from liquid-culture MK [10], platelet production from 3D culture MK was upregulated in a flow chamber compared to static conditions (data not shown). Importantly, more and larger cytoskeletal elongations were observed from 3D than liquid-culture mature MK (Fig 7A and S2 Video). This increased ability to elongate resulted in a significantly higher percentage of proplatelets/platelets (59% ± 4.2%) produced by 3D mature MK than liquid-culture MK (17.7% ± 2%, p<0.05; Fig 7B). These data, combined with those in Figs 2A and 3C, indicate that platelet production relative to initial CD34⁺ cell input was higher in 3D (14 platelets/CD34⁺) than in liquid culture (6 platelets/CD34⁺) on day 16. Furthermore, platelet production from 3D mature MK was still observed up to day 36 (data not shown). These results demonstrated that this 3D environment allowed the recovery of many platelets.

Download:

Fig 7. MK deformation and platelet production in flow conditions.

(A) Stages of MK deformations and reorganization into proplatelets and platelets at 20 minutes of perfusion in 3D (left panel) and in liquid culture (right panel) using Bioflux microfluidic platform to increase platelet formation from mature MK [10]. Images were acquired using the Axiovert 135 transmission optical microscope with 20X Plasdic magnification. Bar = 20 μm. (B) Histogram representation of proplatelet/platelet numbers as a percentage of total adherent cells per field recovered from mature MK obtained in 3D (black bars) and liquid culture (white bars). Data are means ± SEM of 3 independent experiments.*p<0.05.

https://doi.org/10.1371/journal.pone.0136652.g007

Discussion

HSC isolated from hematopoietic tissues differentiate into MK progenitors and then into mature MK, whose function is to terminally release platelets that are essential for bleeding arrest. To improve in vitro platelet production, several attempts are currently developed [9,11,16]. In this study, we demonstrate that the spatial organization conferred by 3D environment sustains an improved MK differentiation, in line with the production of functional platelets.

We demonstrate by structural, functional and transcriptional analyses that the 3D environment provides a delayed of progenitor commitment into MK differentiation, increasing the number of both MK precursors and mature MK, improving the production of functional platelets. Other groups have demonstrated that both CD34⁺ progenitor cell maintenance and expansion were improved by using 3D scaffolds with pore sizes close to 200 μm [3,4,28]. Polysaccharide-based 3D hydrogels with an appropriate composition, structure and elasticity may mimic matrix properties and the bone marrow micro-environment naturally adapted to cell niches [29]. Indeed, porous hydrogels composed of pullulan and dextran displayed several characteristics suitable for studying HSC proliferation and MK differentiation, including their large pore size and high porosity, and also their ability to be enzymatically hydrolyzed [30]. In pullulan/dextran 3D structures, MK progenitors are accommodated inside the large pores favoring cell proximity (Fig 1). This confinement could also concentrate soluble factors such as SCF and TPO favoring CD34⁺ progenitor cell proliferation and MK differentiation. TPO is important not only for HSC and hematopoietic progenitor cell maintenance but also for MK differentiation (reviewed in Kiel and Morrison [31]). In 3D environment, TPO may exert both paracrine and autocrine effects, due to its increased local concentrations [32]. Indeed, cross-linked hydrogels have been shown to bind growth factors and cytokines through ionic interactions with phosphate residues [33]. This confinement was specific to pullulan/dextran 3D hydrogels since we also established that HSC incorporation and MK differentiation were not supported by two other scaffolds: fucoidan cross-linked hydrogels, previously shown to provide proangiogenic activity of endothelial progenitor cells [34], or a fibrin-based matrix shown to enhance HSC proliferation [3] (data not shown). In addition, time-dependent expression of transcription factors in 3D hydrogels confirms longer kinetics of CD34⁺ cell proliferation and the delay of MK differentiation compared with liquid culture. Indeed, the expression of EKLF, c-myb, GATA-1 or FLI-1, involved in early MK differentiation and known to disappear in time in liquid culture [24,25], persisted at late time points in 3D. Furthermore, the expression of transcription factors of early MK progenitors was more important in 3D than in liquid culture. Inversely, the expression of transcription factors of late MK progenitors was more important in liquid culture than in 3D. The second effect of 3D environment is to provide a proliferative advantage of CD34⁺, cells leading to increased numbers of mature MK and to the production of functional platelets. This effect combined with the delayed MK differentiation results in a better maintenance of CD34⁺ cells in 3D environment. This sustained HSC differentiation into MK could be mediated by juxtacrine cellular signaling such as the Notch pathways, by balancing proliferation and differentiation [22,35,36]. Preliminary results based on γ-secretase inhibition by DAPT suggested a Notch pathway implication in the 3D environment (data not shown).

In addition to the specific effect of 3D environment on MK differentiation, our data show that 3D structures support not only MK differentiation but also erythropoietic and myelomonocytic differentiation. Indeed, CD34⁺ cell commitment in other lineages was observed in 3D, as shown by changes of myelomonocytic CD11b and CD14 markers [37,38] and erythropoietic GpA marker [23]; the latter is in line with the persistence of EKLF transcription factor involved in megakaryocyte-erythroid commitment [25]. In addition to endogenously secreted cytokines and growth factors, this effect could be related to SCF persistence within the pores, known to induce CD34⁺ cell commitment in all hematopoietic lineages [39]. Thus, the proliferative advantage of CD34⁺ cells observed in 3D environment is essential to obtain and preserve mature MK but also other mature cells (red blood cells or white blood cells).

The role of polyploidy for increasing platelet formation has been suggested but it still remains unclear [40]. A gene profiling approach established that polyploidization and megakaryocyte differentiation were interrelated in particular via increased cytoplasm volume [41]. However so far, platelet formation was not adressed in these studies. Our results indicate that 3D mature MK sustain platelet production until day 36 compared to day 16 in liquid culture. In a step-by-step comparison of MK differentiation in both conditions, our data could establish the influence of MK polyploidization during their maturation, on platelet production. This is based on recent studies showing the link between polyploidization, demarcation membrane system (DMS) and platelet production [42,43]. High levels of ploidy appeared to improve DMS [42] in mature MK, which is at the origin of proplatelet and platelet formation [43]. Interestingly, the high proportion of released platelets in 3D was consistent with several markers related to the maturation of MK. Indeed, we observed larger MK as well as longer elongations of MK cytoskeleton with increased number of proplatelets in flow conditions. In addition, we observed an increased ploidy of UCB- and peripheral blood- mature MK (Panel C in S3 Fig). This shift towards 4N and 8N in 3D suggests that the 3D structure may regulate not only HSC differentiation but also MK ploidy. A link between polyploidization and terminal MK differentiation has been demonstrated involving, for instance, non-muscle myosin IIB heavy chain repression and inhibition of Rho kinase signaling [44,45]. In addition, preliminary results showed that 3D platelets spread over fibrinogen matrix and upon activation with thrombin, a physiological agonist, reorganized their F-actin cytoskeleton (S4 Fig), as show by the formation of filopodia, lamellipodia and stress fiber [46]. This F-actin cytoskeleton reorganization was similar to that of blood platelets, as previously shown [10]. Furthermore, upon activation with the PAR1-activated peptide, the integrin αIIbβ3 modified its conformation and was stained by PAC1 (Panel B in S4 Fig), an antibody binding only to activated platelets [47–50]. Thus, 3D mature MK exposed to high shear rates on a von Willebrand factor are able to produce platelets responding normally to platelet agonists. Most studies of platelet production from MK were focused on MK migration [9,11,13,16]. Recently, alginate/matrigel gels were shown to accommodate mature MK but proplatelet formation was studied in a microfluidic platform in vitro without studying the influence of 3D environment on platelet formation [9]. In contrast, our model allows the investigation of 3D environment on both MK differentiation from HSC and platelet production in an in vitro microfluidic platform. Thus, this study demonstrates for the first time the effects of 3D environment on MK differentiation and in particular on the improvement of enlargement of mature MK leading to increase the production of platelets. Furthermore, 3D environment is mainly good to keep a continuous supply of CD34⁺ cells to undergo MK differentiation.

Collectively, 3D environment promotes cell clustering, sustains and improves MK differentiation into fully mature MK leading to increase the production of functional platelets. This study provides the first direct evidence that spatial organization and biological cues synergize for efficient MK and platelet production. This 3D environment constitutes a powerful tool for unraveling the physiological mechanisms of megakaryopoiesis and thrombopoiesis in the bone marrow environment. Recent studies showed the feasibility of expanding human induced pluripotent stem cells (iPSCs) into MK underline potential therapeutic applications for generation of platelets [51–53]. Thus, even if a long step forward is necessary between this development and the ultimate goal to provide an alternative to blood-derived platelets, a combination of 3D structures with iPSCs might be of major interest for future therapeutic use.

Supporting Information

S1 Table. Commercial references of the primer mixes used for qPCR.

https://doi.org/10.1371/journal.pone.0136652.s001

(DOCX)

S1 Fig. Schematic outline of steps from 3D cell culture, MK differentiation, mature MK extraction from hydrogels and perfusion, and platelet production.

Step 1: CD34⁺ cells were seeded inside 3D pores at day 0 in presence of 50 nM TPO and 20 ng/mL SCF. Steps 2 and 3: On days 7, 9 and 12, the disks were transferred in new wells and fresh medium containing 20 nM TPO was added. Step 4: Cells excluded from 3D and accumulated at the bottom of the wells were discarded. Step 5: On days 16, 23, 30 and 36, mature MK were extracted from 3D by enzymatic lysis. Step 6: Platelets were produced by mature MK perfusion in microchannels coated with VWF. Steps 7 and 8: At the end of the perfusion, platelets were collected and platelet functions were assessed. Abbreviations: TPO, thrombopoietin; SCF, stem cell factor; MK, megakaryocytes; VWF, von Willebrand factor.

https://doi.org/10.1371/journal.pone.0136652.s002

(DOCX)

S2 Fig. Effect of 3D environment on the expression of myelomonocytic and erythropoietic markers.

(A) Frequency of CD41^-/CD11b⁺/CD14^-, CD41^-/CD11b⁺/CD14⁺ (both myelomonocytic cells) and CD41^-/CD11b^-/CD14⁺ (macrophages) cells in 3D (closed circles, dotted lines) and liquid culture (open squares, full lines) between day 7 and day 36. (B) Frequency of CD41^-/GpA^- and CD41^-/GpA⁺ (erythrocytic cells) cells in 3D (closed circles, dotted lines) and liquid culture (open squares, full lines) between day 7 and day 36. Data are means ± SEM of 4 independent experiments. *p<0.05. In 3D, late time points (days 23 and 36) were compared to day 7. Results indicate that the effect of 3D environment also results in commitment into the erythropoietic and myelomonocytic lineages during a second wave of differentiation that takes place between day 16 and day 36.

https://doi.org/10.1371/journal.pone.0136652.s003

(DOCX)

S3 Fig. Proliferation and differentiation of neonatal and adult CD34⁺ cells inside 3D environment.

(A) Bone marrow and peripheral blood cell proliferation inside 3D pores, 12 days after seeding. Images were acquired using the Axiovert 135 transmission optical microscope with 20X Plasdic magnification. Bar = 20 μm. (B) CD41/CD34 dot plots of one representative experiment in 3D and liquid culture on day 12. Similar results are obtained with neonatal or adult CD34⁺ cells with the persistence of non-megakaryocytic cells and cell progenitors (CD34⁺/CD41^- cells); these cells could still commit in the megakaryocytic lineage. (C) Ploidy analysis of CD41⁺/CD42b⁺ peripheral blood cells in 3D (black bars) compared to liquid culture (white bars). Data are means ± SEM of 3 independent experiments. Results show higher percentages of 8N ploidy classes in 3D cells (25.3% ± 6.1%) than in liquid-culture cells (15.9% ± 4.9%), whereas 2N ploidy was more frequent in liquid culture (48.1% ± 6.3%) than in 3D (39.3% ± 6.4%). Abbreviation: UCB, umbilical cord blood.

https://doi.org/10.1371/journal.pone.0136652.s004

(DOCX)

S4 Fig. Functional properties of 3D platelets collected at the exit of the microchannels.

(A) Representative images of CD41 (green)/F-actin (red) staining on platelets collected after perfusion of 3D mature MK in microfluidic platform. Filopodia (arrowhead) and stress fibers (arrow) are visible on activated platelets. (B) Representative images of PAC1 staining of integrin αIIbβ3 activated (green) and of F-actin staining (red) on platelets collected after perfusion of 3D mature MK in microfluidic platform. Lamellipodia (asterisk) are visible on activated platelets. Images were acquired using the Axio Observer D1 fluorescence optical microscope with 63X Plasdic magnification. Bar = 2 μm.

https://doi.org/10.1371/journal.pone.0136652.s005

(DOCX)

S1 Video. Platelet production in flow conditions from 3D mature MK.

The video shows extremely long MK elongations similar to beads-on-a-thread. Proplatelets and platelets are also visible in the last section of the video. Mature and viable MK were recovered from 3D or liquid culture on day 16 and perfused at a shear rate of 1800 s^-1 for 45 min on VWF-coated microchannels. Different steps of platelet production were visualized in real-time using the Axiovert 135 transmission optical microscope with 20X Plasdic magnification. Digital images were recorded at 0.25 images/s using Replay software (Microvision Instruments). For visualization, Archimed software (Microvision Instruments) was used to grab frames and record at a velocity of 10 images/sec (40-fold acceleration). Bar = 20 μm.

https://doi.org/10.1371/journal.pone.0136652.s006

(DOCX)

S2 Video. Platelet production in flow conditions from liquid-culture mature MK.

Compared to mature MK obtained from 3D culture, notice the shorter elongations interacting with the surface during the first part of the video and the reduced production of proplatelets and platelets during the second part of the video. Mature and viable MK were recovered from 3D or liquid culture on day 16 and perfused at a shear rate of 1800 s^-1 for 45 min on VWF-coated microchannels. Different steps of platelet production were visualized in real-time using the Axiovert 135 transmission optical microscope with 20X Plasdic magnification. Digital images were recorded at 0.25 images/s using Replay software (Microvision Instruments). For visualization, Archimed software (Microvision Instruments) was used to grab frames and record at a velocity of 10 images/sec (40-fold acceleration). Bar = 20 μm.

https://doi.org/10.1371/journal.pone.0136652.s007

(DOCX)

S1 Materials and Methods.

https://doi.org/10.1371/journal.pone.0136652.s008

(DOCX)

Acknowledgments

The authors thank the Cell Therapy Unit of Saint Louis Hospital (Paris) for providing blood samples. This study was approved by the ethics committee/institutional review board “Assistance Publique-Hôpitaux de Paris, Cord Blood Bank, Saint-Louis Hospital, Paris, France” with women’s written informed consent. We also thank Muriel Andrieu and Karine Labroquère of the Cochin Cytometry and Immunobiology Facility for the use of the BD CANTO 2 and BD LSR II cytometers, Rachida Aid for providing hydrogels and enzymes, and Samira Benadda and Fabien Legrand for the use of the Leica microscope system (IFR Claude Bernard, Paris). We thank Bruno Saubaméa of the Molecular and Cellular Imagery Platform for Leica transmission optical microscopy. We thank Isabelle Dusanter-Fourt and Evelyne Lauret (UMR_S 1016 and University Paris Descartes) for helpful discussions and critical reading of the manuscript. These studies were made available through the funding from DIM Stem Pole, INSERM, Universities Paris Descartes, Paris Diderot, Paris Nord and grants from ANR (ANR-09-EBIO-001-01; ANR-09-EBIO-001-09; ANR-10-EMMA-009-01; ANR-11-BSV-010-01).

Author Contributions

Conceived and designed the experiments: DB DL CLV SPC. Performed the experiments: APN SPC SG AK SMD. Analyzed the data: APN SPC SG AK SMD. Contributed reagents/materials/analysis tools: SG SMD CLV. Wrote the paper: DB CLV DL AK APN.

References

1. Cabrita GJ, Ferreira BS, da Silva CL, Goncalves R, Almeida-Porada G, Cabral JM. (2003) Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 21(5): 233–240. pmid:12727385
- View Article
- PubMed/NCBI
- Google Scholar
2. Liu H, Roy K (2005) Biomimetic three-dimensional cultures significantly increase hematopoietic differentiation efficacy of embryonic stem cells. Tissue Eng 11(1–2): 319–330. pmid:15738685
- View Article
- PubMed/NCBI
- Google Scholar
3. Ventura Ferreira MS, Jahnen-Dechent W, Labude N, Bovi M, Hieronymus T, Zenke M, et al. (2012) Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support. Biomaterials 33(29): 6987–6997. pmid:22800538
- View Article
- PubMed/NCBI
- Google Scholar
4. Raic A, Rodling L, Kalbacher H, Lee-Thedieck C (2014) Biomimetic macroporous PEG hydrogels as 3D scaffolds for the multiplication of human hematopoietic stem and progenitor cells. Biomaterials 35(3): 929–940. pmid:24176196
- View Article
- PubMed/NCBI
- Google Scholar
5. Machlus KR, Italiano JE Jr. (2013) The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol 201(6): 785–796. pmid:23751492
- View Article
- PubMed/NCBI
- Google Scholar
6. Kaushansky K (2005) Thrombopoietin and the hematopoietic stem cell. Ann N Y Acad Sci 1044: 139–141. pmid:15958707
- View Article
- PubMed/NCBI
- Google Scholar
7. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, et al. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10(1): 64–71. pmid:14702636
- View Article
- PubMed/NCBI
- Google Scholar
8. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, et al. (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317(5845): 1767–1770. pmid:17885137
- View Article
- PubMed/NCBI
- Google Scholar
9. Thon JN, Mazutis L, Wu S, Sylman JL, Ehrlicher A, Machlus KR, et al. (2014) Platelet bioreactor-on-a-chip. Blood 124: 1857–1867. pmid:25606631
- View Article
- PubMed/NCBI
- Google Scholar
10. Dunois-Larde C, Capron C, Fichelson S, Bauer T, Cramer-Borde E, Baruch D. (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114(9): 1875–1883. pmid:19525480
- View Article
- PubMed/NCBI
- Google Scholar
11. Nakagawa Y, Nakamura S, Nakajima M, Endo H, Dohda T, Takayama N, et al. (2013) Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol 41(8): 742–748. pmid:23618622
- View Article
- PubMed/NCBI
- Google Scholar
12. Pallotta I, Lovett M, Rice W, Kaplan DL, Balduini A (2009) Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis. PLoS One 4(12): e8359. pmid:20027303
- View Article
- PubMed/NCBI
- Google Scholar
13. Pallotta I, Lovett M, Kaplan DL, Balduini A (2011) Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes. Tissue Eng Part C Methods 17(12): 1223–1232. pmid:21895494
- View Article
- PubMed/NCBI
- Google Scholar
14. Reems JA, Pineault N, Sun S (2010) In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev 24(1): 33–43. pmid:19962573
- View Article
- PubMed/NCBI
- Google Scholar
15. Malara A, Gruppi C, Pallotta I, Spedden E, Tenni R, Raspanti M, et al. (2011) Extracellular matrix structure and nano-mechanics determine megakaryocyte function. Blood 118(16): 4449–4453. pmid:21828129
- View Article
- PubMed/NCBI
- Google Scholar
16. Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC (2009) Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 37(1): 101–110. pmid:19013002
- View Article
- PubMed/NCBI
- Google Scholar
17. Lavergne M, Derkaoui M, Delmau C, Letourneur D, Uzan G, Le Visage C. (2012) Porous polysaccharide-based scaffolds for human endothelial progenitor cells. Macromol Biosci 12(7): 901–910. pmid:22696505
- View Article
- PubMed/NCBI
- Google Scholar
18. Hamidi S, Letourneur D, Aid-Launais R, Di Stefano A, Vainchenker W, Norol F, et al. (2014) Fucoidan Promotes Early Step of Cardiac Differentiation from Human Embryonic Stem Cells and Long-Term Maintenance of Beating Areas. Tissue Eng Part A. 20(7–8): 1285–1294. pmid:24354596
- View Article
- PubMed/NCBI
- Google Scholar
19. Autissier A, Le Visage C, Pouzet C, Chaubet F, Letourneur D (2010) Fabrication of porous polysaccharide-based scaffolds using a combined freeze-drying/cross-linking process. Acta Biomater 6(9): 3640–3648. pmid:20215057
- View Article
- PubMed/NCBI
- Google Scholar
20. Le Visage C, Gournay O, Benguirat N, Hamidi S, Chaussumier L, Mougenot N, et al. (2012) Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Eng Part A 18(1–2): 35–44. pmid:21770864
- View Article
- PubMed/NCBI
- Google Scholar
21. Robert A, Cortin V, Garnier A, Pineault N (2012) Megakaryocyte and platelet production from human cord blood stem cells. Methods Mol Biol 788: 219–247. pmid:22130711
- View Article
- PubMed/NCBI
- Google Scholar
22. Poirault-Chassac S, Six E, Catelain C, Lavergne M, Villeval JL, Vainchenker W, et al. (2010) Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation. Blood 116(25): 5670–5678. pmid:20829371
- View Article
- PubMed/NCBI
- Google Scholar
23. Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y, et al. (2009) A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 114(8): 1506–1517. pmid:19478046
- View Article
- PubMed/NCBI
- Google Scholar
24. Chang Y, Bluteau D, Debili N, Vainchenker W (2007) From hematopoietic stem cells to platelets. J Thromb Haemost 5 Suppl 1: 318–327. pmid:17635743
- View Article
- PubMed/NCBI
- Google Scholar
25. Dore LC, Crispino JD (2011) Transcription factor networks in erythroid cell and megakaryocyte development. Blood 118(2): 231–239. pmid:21622645
- View Article
- PubMed/NCBI
- Google Scholar
26. Tijssen MR, Ghevaert C (2013) Transcription factors in late megakaryopoiesis and related platelet disorders. J Thromb Haemost 11(4): 593–604. pmid:23311859
- View Article
- PubMed/NCBI
- Google Scholar
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402–408. pmid:11846609
- View Article
- PubMed/NCBI
- Google Scholar
28. Tiwari A, Tursky ML, Kirkland MA, Pande G (2014) Expansion of human hematopoietic stem/progenitor cells on decellularized matrix scaffolds. Curr Protoc Stem Cell Biol 28: 1C 15 11–11C 15 15.
- View Article
- Google Scholar
29. Robert D, Fayol D, Le Visage C, Frasca G, Brule S, Ménager C, et al. (2010) Magnetic micro-manipulations to probe the local physical properties of porous scaffolds and to confine stem cells. Biomaterials 31(7): 1586–1595. pmid:19932922
- View Article
- PubMed/NCBI
- Google Scholar
30. Abed A, Assoul N, Ba M, Derkaoui SM, Portes P, Louedec L, et al. (2011) Influence of polysaccharide composition on the biocompatibility of pullulan/dextran-based hydrogels. J Biomed Mater Res A 96(3): 535–542. pmid:21254385
- View Article
- PubMed/NCBI
- Google Scholar
31. Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8(4): 290–301. pmid:18323850
- View Article
- PubMed/NCBI
- Google Scholar
32. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, et al. (2001) Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97(10): 3075–3085. pmid:11342433
- View Article
- PubMed/NCBI
- Google Scholar
33. Purnama A, Aid-Launais R, Haddad O, Maire M, Mantovani D, Letourneur D, et al. (2013) Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice. Drug Delivery and Translational Research: 1–11.
- View Article
- Google Scholar
34. Thebaud NB, Pierron D, Bareille R, Le Visage C, Letourneur D, Bordenave L. (2007) Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: a pre-requisite for vascular tissue engineering. J Mater Sci Mater Med 18(2): 339–345. pmid:17323167
- View Article
- PubMed/NCBI
- Google Scholar
35. Cortegano I, Melgar-Rojas P, Luna-Zurita L, Siguero-Alvarez M, Marcos MA, Gaspar ML, et al. (2014) Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis. Cell Death Differ 21(7): 1081–1094. pmid:24583642
- View Article
- PubMed/NCBI
- Google Scholar
36. Mercher T, Cornejo MG, Sears C, Kindler T, Moore SA, Maillard I, et al. (2008) Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 3(3): 314–326. pmid:18786418
- View Article
- PubMed/NCBI
- Google Scholar
37. Appleby LJ, Nausch N, Midzi N, Mduluza T, Allen JE, Mutapi F. (2013) Sources of heterogeneity in human monocyte subsets. Immunol Lett 152(1): 32–41. pmid:23557598
- View Article
- PubMed/NCBI
- Google Scholar
38. Thacker E, Summerfield A, McCullough K, Ezquerra A, Dominguez J, Alonso F, et al. (2001) Summary of workshop findings for porcine myelomonocytic markers. Vet Immunol Immunopathol 80(1–2): 93–109. pmid:11445221
- View Article
- PubMed/NCBI
- Google Scholar
39. McNiece IK, Briddell RA (1995) Stem cell factor. J Leukoc Biol 58(1): 14–22. pmid:7542304
- View Article
- PubMed/NCBI
- Google Scholar
40. Zimmet J, Ravid K (2000) Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 28(1): 3–16. pmid:10658672
- View Article
- PubMed/NCBI
- Google Scholar
41. Raslova H, Kauffmann A, Sekkai D, Ripoche H, Larbret F, Robert T, et al. (2007) Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood 109(8): 3225–3234. pmid:17170127
- View Article
- PubMed/NCBI
- Google Scholar
42. Avanzi MP, Goldberg F, Davila J, Langhi D, Chiattone C, Mitchell WB. (2014) Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation. Br J Haematol 164(6): 867–876. pmid:24383889
- View Article
- PubMed/NCBI
- Google Scholar
43. Eckly A, Heijnen H, Pertuy F, Geerts W, Proamer F, Rinckel JY, et al. (2013) Biogenesis of the demarcation membrane system (DMS) in megakaryocytes. Blood 123(6): 921–930. pmid:24152908
- View Article
- PubMed/NCBI
- Google Scholar
44. Lordier L, Bluteau D, Jalil A, Legrand C, Pan J, Rameau P, et al. (2012) RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun 3: 717. pmid:22395608
- View Article
- PubMed/NCBI
- Google Scholar
45. Chang Y, Aurade F, Larbret F, Zhang Y, Le Couedic JP, Momeux L, et al. (2007) Proplatelet formation is regulated by the Rho/ROCK pathway. Blood 109 (10): 4229–4236. pmid:17244674
- View Article
- PubMed/NCBI
- Google Scholar
46. Hartwig JH (1992) Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 118(6): 1421–1442. pmid:1325975
- View Article
- PubMed/NCBI
- Google Scholar
47. Lu Q, Malinauskas RA (2011) Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. Artif Organs 35(2): 137–144. pmid:20946295
- View Article
- PubMed/NCBI
- Google Scholar
48. Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260(20): 11107–11114. pmid:2411729
- View Article
- PubMed/NCBI
- Google Scholar
49. Jirouskova M, Jaiswal JK, Coller BS (2007) Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. Blood 109(12): 5260–5269. pmid:17332246
- View Article
- PubMed/NCBI
- Google Scholar
50. Mazharian A, Roger S, Berrou E, Adam F, Kauskot A, Nurden P, et al. (2007) Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization. J Biol Chem 282(8): 5478–5487. pmid:17200114
- View Article
- PubMed/NCBI
- Google Scholar
51. Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, et al. (2014) Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem Cells. Cell Stem Cell 14(4): 535–548. pmid:24529595
- View Article
- PubMed/NCBI
- Google Scholar
52. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, et al. (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13): 2817–2830. pmid:21098095
- View Article
- PubMed/NCBI
- Google Scholar
53. Takayama N, Eto K (2012) Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application. Cell Mol Life Sci 69(20): 3419–3428. pmid:22527724
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Cabrita GJ, Ferreira BS, da Silva CL, Goncalves R, Almeida-Porada G, Cabral JM. (2003) Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 21(5): 233–240. pmid:12727385
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Liu H, Roy K (2005) Biomimetic three-dimensional cultures significantly increase hematopoietic differentiation efficacy of embryonic stem cells. Tissue Eng 11(1–2): 319–330. pmid:15738685
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Ventura Ferreira MS, Jahnen-Dechent W, Labude N, Bovi M, Hieronymus T, Zenke M, et al. (2012) Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support. Biomaterials 33(29): 6987–6997. pmid:22800538
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Raic A, Rodling L, Kalbacher H, Lee-Thedieck C (2014) Biomimetic macroporous PEG hydrogels as 3D scaffolds for the multiplication of human hematopoietic stem and progenitor cells. Biomaterials 35(3): 929–940. pmid:24176196
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Machlus KR, Italiano JE Jr. (2013) The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol 201(6): 785–796. pmid:23751492
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Kaushansky K (2005) Thrombopoietin and the hematopoietic stem cell. Ann N Y Acad Sci 1044: 139–141. pmid:15958707
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, et al. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10(1): 64–71. pmid:14702636
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, et al. (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317(5845): 1767–1770. pmid:17885137
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Thon JN, Mazutis L, Wu S, Sylman JL, Ehrlicher A, Machlus KR, et al. (2014) Platelet bioreactor-on-a-chip. Blood 124: 1857–1867. pmid:25606631
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Dunois-Larde C, Capron C, Fichelson S, Bauer T, Cramer-Borde E, Baruch D. (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114(9): 1875–1883. pmid:19525480
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Nakagawa Y, Nakamura S, Nakajima M, Endo H, Dohda T, Takayama N, et al. (2013) Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol 41(8): 742–748. pmid:23618622
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Pallotta I, Lovett M, Rice W, Kaplan DL, Balduini A (2009) Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis. PLoS One 4(12): e8359. pmid:20027303
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Pallotta I, Lovett M, Kaplan DL, Balduini A (2011) Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes. Tissue Eng Part C Methods 17(12): 1223–1232. pmid:21895494
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Reems JA, Pineault N, Sun S (2010) In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev 24(1): 33–43. pmid:19962573
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Malara A, Gruppi C, Pallotta I, Spedden E, Tenni R, Raspanti M, et al. (2011) Extracellular matrix structure and nano-mechanics determine megakaryocyte function. Blood 118(16): 4449–4453. pmid:21828129
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC (2009) Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 37(1): 101–110. pmid:19013002
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Lavergne M, Derkaoui M, Delmau C, Letourneur D, Uzan G, Le Visage C. (2012) Porous polysaccharide-based scaffolds for human endothelial progenitor cells. Macromol Biosci 12(7): 901–910. pmid:22696505
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Hamidi S, Letourneur D, Aid-Launais R, Di Stefano A, Vainchenker W, Norol F, et al. (2014) Fucoidan Promotes Early Step of Cardiac Differentiation from Human Embryonic Stem Cells and Long-Term Maintenance of Beating Areas. Tissue Eng Part A. 20(7–8): 1285–1294. pmid:24354596
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Autissier A, Le Visage C, Pouzet C, Chaubet F, Letourneur D (2010) Fabrication of porous polysaccharide-based scaffolds using a combined freeze-drying/cross-linking process. Acta Biomater 6(9): 3640–3648. pmid:20215057
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. Le Visage C, Gournay O, Benguirat N, Hamidi S, Chaussumier L, Mougenot N, et al. (2012) Mesenchymal stem cell delivery into rat infarcted myocardium using a porous polysaccharide-based scaffold: a quantitative comparison with endocardial injection. Tissue Eng Part A 18(1–2): 35–44. pmid:21770864
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. Robert A, Cortin V, Garnier A, Pineault N (2012) Megakaryocyte and platelet production from human cord blood stem cells. Methods Mol Biol 788: 219–247. pmid:22130711
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. Poirault-Chassac S, Six E, Catelain C, Lavergne M, Villeval JL, Vainchenker W, et al. (2010) Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation. Blood 116(25): 5670–5678. pmid:20829371
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref23] 23. Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y, et al. (2009) A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 114(8): 1506–1517. pmid:19478046
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref24] 24. Chang Y, Bluteau D, Debili N, Vainchenker W (2007) From hematopoietic stem cells to platelets. J Thromb Haemost 5 Suppl 1: 318–327. pmid:17635743
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref25] 25. Dore LC, Crispino JD (2011) Transcription factor networks in erythroid cell and megakaryocyte development. Blood 118(2): 231–239. pmid:21622645
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref26] 26. Tijssen MR, Ghevaert C (2013) Transcription factors in late megakaryopoiesis and related platelet disorders. J Thromb Haemost 11(4): 593–604. pmid:23311859
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref27] 27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402–408. pmid:11846609
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref28] 28. Tiwari A, Tursky ML, Kirkland MA, Pande G (2014) Expansion of human hematopoietic stem/progenitor cells on decellularized matrix scaffolds. Curr Protoc Stem Cell Biol 28: 1C 15 11–11C 15 15.
View Article
Google Scholar

[110] View Article

[111] Google Scholar

[ref29] 29. Robert D, Fayol D, Le Visage C, Frasca G, Brule S, Ménager C, et al. (2010) Magnetic micro-manipulations to probe the local physical properties of porous scaffolds and to confine stem cells. Biomaterials 31(7): 1586–1595. pmid:19932922
View Article
PubMed/NCBI
Google Scholar

[113] View Article

[114] PubMed/NCBI

[115] Google Scholar

[ref30] 30. Abed A, Assoul N, Ba M, Derkaoui SM, Portes P, Louedec L, et al. (2011) Influence of polysaccharide composition on the biocompatibility of pullulan/dextran-based hydrogels. J Biomed Mater Res A 96(3): 535–542. pmid:21254385
View Article
PubMed/NCBI
Google Scholar

[117] View Article

[118] PubMed/NCBI

[119] Google Scholar

[ref31] 31. Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8(4): 290–301. pmid:18323850
View Article
PubMed/NCBI
Google Scholar

[121] View Article

[122] PubMed/NCBI

[123] Google Scholar

[ref32] 32. Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, et al. (2001) Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97(10): 3075–3085. pmid:11342433
View Article
PubMed/NCBI
Google Scholar

[125] View Article

[126] PubMed/NCBI

[127] Google Scholar

[ref33] 33. Purnama A, Aid-Launais R, Haddad O, Maire M, Mantovani D, Letourneur D, et al. (2013) Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice. Drug Delivery and Translational Research: 1–11.
View Article
Google Scholar

[129] View Article

[130] Google Scholar

[ref34] 34. Thebaud NB, Pierron D, Bareille R, Le Visage C, Letourneur D, Bordenave L. (2007) Human endothelial progenitor cell attachment to polysaccharide-based hydrogels: a pre-requisite for vascular tissue engineering. J Mater Sci Mater Med 18(2): 339–345. pmid:17323167
View Article
PubMed/NCBI
Google Scholar

[132] View Article

[133] PubMed/NCBI

[134] Google Scholar

[ref35] 35. Cortegano I, Melgar-Rojas P, Luna-Zurita L, Siguero-Alvarez M, Marcos MA, Gaspar ML, et al. (2014) Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis. Cell Death Differ 21(7): 1081–1094. pmid:24583642
View Article
PubMed/NCBI
Google Scholar

[136] View Article

[137] PubMed/NCBI

[138] Google Scholar

[ref36] 36. Mercher T, Cornejo MG, Sears C, Kindler T, Moore SA, Maillard I, et al. (2008) Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 3(3): 314–326. pmid:18786418
View Article
PubMed/NCBI
Google Scholar

[140] View Article

[141] PubMed/NCBI

[142] Google Scholar

[ref37] 37. Appleby LJ, Nausch N, Midzi N, Mduluza T, Allen JE, Mutapi F. (2013) Sources of heterogeneity in human monocyte subsets. Immunol Lett 152(1): 32–41. pmid:23557598
View Article
PubMed/NCBI
Google Scholar

[144] View Article

[145] PubMed/NCBI

[146] Google Scholar

[ref38] 38. Thacker E, Summerfield A, McCullough K, Ezquerra A, Dominguez J, Alonso F, et al. (2001) Summary of workshop findings for porcine myelomonocytic markers. Vet Immunol Immunopathol 80(1–2): 93–109. pmid:11445221
View Article
PubMed/NCBI
Google Scholar

[148] View Article

[149] PubMed/NCBI

[150] Google Scholar

[ref39] 39. McNiece IK, Briddell RA (1995) Stem cell factor. J Leukoc Biol 58(1): 14–22. pmid:7542304
View Article
PubMed/NCBI
Google Scholar

[152] View Article

[153] PubMed/NCBI

[154] Google Scholar

[ref40] 40. Zimmet J, Ravid K (2000) Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 28(1): 3–16. pmid:10658672
View Article
PubMed/NCBI
Google Scholar

[156] View Article

[157] PubMed/NCBI

[158] Google Scholar

[ref41] 41. Raslova H, Kauffmann A, Sekkai D, Ripoche H, Larbret F, Robert T, et al. (2007) Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood 109(8): 3225–3234. pmid:17170127
View Article
PubMed/NCBI
Google Scholar

[160] View Article

[161] PubMed/NCBI

[162] Google Scholar

[ref42] 42. Avanzi MP, Goldberg F, Davila J, Langhi D, Chiattone C, Mitchell WB. (2014) Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation. Br J Haematol 164(6): 867–876. pmid:24383889
View Article
PubMed/NCBI
Google Scholar

[164] View Article

[165] PubMed/NCBI

[166] Google Scholar

[ref43] 43. Eckly A, Heijnen H, Pertuy F, Geerts W, Proamer F, Rinckel JY, et al. (2013) Biogenesis of the demarcation membrane system (DMS) in megakaryocytes. Blood 123(6): 921–930. pmid:24152908
View Article
PubMed/NCBI
Google Scholar

[168] View Article

[169] PubMed/NCBI

[170] Google Scholar

[ref44] 44. Lordier L, Bluteau D, Jalil A, Legrand C, Pan J, Rameau P, et al. (2012) RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun 3: 717. pmid:22395608
View Article
PubMed/NCBI
Google Scholar

[172] View Article

[173] PubMed/NCBI

[174] Google Scholar

[ref45] 45. Chang Y, Aurade F, Larbret F, Zhang Y, Le Couedic JP, Momeux L, et al. (2007) Proplatelet formation is regulated by the Rho/ROCK pathway. Blood 109 (10): 4229–4236. pmid:17244674
View Article
PubMed/NCBI
Google Scholar

[176] View Article

[177] PubMed/NCBI

[178] Google Scholar

[ref46] 46. Hartwig JH (1992) Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 118(6): 1421–1442. pmid:1325975
View Article
PubMed/NCBI
Google Scholar

[180] View Article

[181] PubMed/NCBI

[182] Google Scholar

[ref47] 47. Lu Q, Malinauskas RA (2011) Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. Artif Organs 35(2): 137–144. pmid:20946295
View Article
PubMed/NCBI
Google Scholar

[184] View Article

[185] PubMed/NCBI

[186] Google Scholar

[ref48] 48. Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260(20): 11107–11114. pmid:2411729
View Article
PubMed/NCBI
Google Scholar

[188] View Article

[189] PubMed/NCBI

[190] Google Scholar

[ref49] 49. Jirouskova M, Jaiswal JK, Coller BS (2007) Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. Blood 109(12): 5260–5269. pmid:17332246
View Article
PubMed/NCBI
Google Scholar

[192] View Article

[193] PubMed/NCBI

[194] Google Scholar

[ref50] 50. Mazharian A, Roger S, Berrou E, Adam F, Kauskot A, Nurden P, et al. (2007) Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization. J Biol Chem 282(8): 5478–5487. pmid:17200114
View Article
PubMed/NCBI
Google Scholar

[196] View Article

[197] PubMed/NCBI

[198] Google Scholar

[ref51] 51. Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, et al. (2014) Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem Cells. Cell Stem Cell 14(4): 535–548. pmid:24529595
View Article
PubMed/NCBI
Google Scholar

[200] View Article

[201] PubMed/NCBI

[202] Google Scholar

[ref52] 52. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, et al. (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207(13): 2817–2830. pmid:21098095
View Article
PubMed/NCBI
Google Scholar

[204] View Article

[205] PubMed/NCBI

[206] Google Scholar

[ref53] 53. Takayama N, Eto K (2012) Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application. Cell Mol Life Sci 69(20): 3419–3428. pmid:22527724
View Article
PubMed/NCBI
Google Scholar

[208] View Article

[209] PubMed/NCBI

[210] Google Scholar

Figures

Abstract

Introduction

Materials and Methods

Three-dimensional hydrogels

CD34+ cell culture and differentiation

Results

Kinetics of cell growth in 3D environment

MK differentiation in 3D environment

Cell ploidy in 3D environment.

MK differentiation from adult cells

Mature MK cultured in 3D produce more platelets in flow conditions than liquid-culture MK

Discussion

Supporting Information

S1 Table. Commercial references of the primer mixes used for qPCR.

S1 Fig. Schematic outline of steps from 3D cell culture, MK differentiation, mature MK extraction from hydrogels and perfusion, and platelet production.

S2 Fig. Effect of 3D environment on the expression of myelomonocytic and erythropoietic markers.

S3 Fig. Proliferation and differentiation of neonatal and adult CD34+ cells inside 3D environment.

S4 Fig. Functional properties of 3D platelets collected at the exit of the microchannels.

S1 Video. Platelet production in flow conditions from 3D mature MK.

S2 Video. Platelet production in flow conditions from liquid-culture mature MK.

S1 Materials and Methods.

Acknowledgments

Author Contributions

References

CD34⁺ cell culture and differentiation

S3 Fig. Proliferation and differentiation of neonatal and adult CD34⁺ cells inside 3D environment.